Science
Mechanism of Action
Acting as a molecular delivery system, it penetrates the lipid barrier up to 97 times more efficiently than standard Tranexamic Acid. Once absorbed, skin enzymes gradually convert it into active acid over a 12-hour period, where it inhibits the plasminogen/plasmin pathway and reduces inflammatory mediators like PGE2 to suppress melanin synthesis and tyrosinase activity.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Clinical trials at 2% concentration demonstrated a 16% reduction in the sharpness of pigmented spot contours and a 24% increase in skin radiance over 8 weeks.
- 02 A 12-week study confirmed significant improvements in melasma severity and overall skin tone uniformity.
- 03 In vitro data indicates 2% TXC promotes collagen synthesis in human fibroblasts, suggesting benefits for structural skin firmness.
Transparency
Dusting Analysis
Because it is a premium, high-efficacy ingredient often marketed under trademarked names like TXC, it is frequently included at 'label claim' levels (under 0.5%) which lack the clinical power seen in the 2% validation studies.
The Formula
Formulation
Stability
Heat sensitive; must be processed below 80°C, ideally dissolving in glycols at 60-70°C. It creates a signature opaque, milky aesthetic in oil-based formulas.
Synergies
- Glycols
- Photostable UV filters
- Lipophilic antioxidants
Conflicts
- Strong anionic surfactants
- Anionic thickeners
- Specific unstable fragrance compounds
Safety
Safety Profile
Officially approved in Japan as a brightening quasi-drug active at 3%. Repeated patch testing confirms it is non-irritating even at maximum concentrations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A technologically superior form of Tranexamic Acid that provides deep-reaching pigment correction and excellent stability for advanced skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources